ArticleMolecular neurobiology2026
miR-6836-5p Drives Astrocyte Pro-survival Signaling Through DLG2-Hippo-YAP Pathway Under AQP4-IgG + ve NMOSD Stress.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy mainly driven by serum antibodies against aquaporin-4 (AQP4-IgG). While antibody-mediated injury to astrocytes is well documented, the intrinsic cellular responses that influence astrocyte survival under such stress remain poorly understood. In this study, differentiated U87MG astrocytoma cells served as an in vitro model to examine the effects of AQP4-IgG + ve NMOSD patient sera on microRNA-mediated signaling. Small RNA sequencing and qRT-PCR revealed that hsa-miR-6836-5p was the most strongly induced miRNA within 4 h of exposure, consistent with the peak downregulation of AQP4. Functional enrichment and target prediction identified the Hippo-YAP signaling pathway, with Discs Large Homolog 2 (DLG2) as a key downstream target. AQP4-IgG + ve sera reduced DLG2 expression, decreased LATS1 and YAP phosphorylation, and upregulated YAP-dependent pro-survival genes (CTGF, CYR61, GLI2), along with an increased BCL-2/BAX ratio, initiating an acute pro-survival response. Inhibition of miR-6836-5p restored DLG2 levels, reactivated the Hippo signaling pathway, and reinstated apoptotic signaling. These findings unveil a novel miR-6836-5p-DLG2-Hippo-YAP axis that promotes pro-survival signaling in astrocytes under autoimmune stress, indicating miR-6836-5p as a potential molecular regulator of astrocyte fate in NMOSD.
Indexed as
Identifiers
42399450What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.